BRCA1 and posterior cortical atrophy: BRCA2 PVs are associated with a more aggressive PCa phenotype than BRCA1 PVs [11, 12, 20, 23, 46], and the results may hence reflect that BRCA2 carriers are more likely than BRCA1 carriers to have clinically significant PCa which is diagnosed regardless of screening.